Pipeline Review for Non-Hodgkin Lymphoma: H1 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Non-Hodgkin Lymphoma - Pipeline Review, H1 2018" report has been added to ResearchAndMarkets.com's offering.

The pipeline guide provides a snapshot of the global therapeutic landscape of Non-Hodgkin Lymphoma (Oncology).

The pipeline guide reviews pipeline therapeutics for Non-Hodgkin Lymphoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Non-Hodgkin Lymphoma (Oncology) therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Non-Hodgkin Lymphoma (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Non-Hodgkin Lymphoma (Oncology).

Key Topics Covered

  1. Introduction
  2. Non-Hodgkin Lymphoma - Overview
  3. Non-Hodgkin Lymphoma - Therapeutics Development
  4. Non-Hodgkin Lymphoma - Therapeutics Assessment
  5. Non-Hodgkin Lymphoma - Companies Involved in Therapeutics Development
  6. Non-Hodgkin Lymphoma - Drug Profiles
  7. Non-Hodgkin Lymphoma - Dormant Projects
  8. Non-Hodgkin Lymphoma - Discontinued Products
  9. Non-Hodgkin Lymphoma - Product Development Milestones
  10. Appendix

Companies Mentioned

  • 3SBio Inc
  • 4SC AG
  • Affitech A/S
  • Agios Pharmaceuticals Inc
  • Aileron Therapeutics Inc
  • Allinky Biopharma
  • Altor BioScience Corp
  • BioLineRx Ltd
  • BioSight Ltd
  • Biothera Pharmaceutical Inc
  • Bristol-Myers Squibb Co
  • Calithera Biosciences Inc
  • CARsgen Therapeutics Ltd
  • Debiopharm International SA
  • H3 Biomedicine Inc
  • Heidelberg Pharma AG
  • Hualan Biological Engineering Inc
  • Hutchison MediPharma Ltd
  • IGF Oncology LLC
  • Ignyta Inc
  • Immune Design Corp
  • ImmunGene Inc
  • KAHR medical Ltd
  • Kainos Medicine Inc
  • MacroGenics Inc
  • Meabco AS
  • Miltenyi Biotec GmbH
  • Miragen Therapeutics Inc
  • Mirati Therapeutics Inc
  • Mitsubishi Tanabe Pharma Corp
  • NovImmune SA
  • Oncobiologics Inc
  • Protheragen Inc
  • Quimatryx SL
  • Vyriad Inc
  • and many more...

For more information about this report visit https://www.researchandmarkets.com/research/tbv5ln/pipeline_review?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Lymphoma Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Lymphoma Drugs